Integra LifeSciences Holdings Corporation (IART) vs LB Pharmaceuticals Inc Common Stock (LBRX)

A side-by-side comparison of Integra LifeSciences Holdings Corporation and LB Pharmaceuticals Inc Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IART vs LBRX

growth of $100 · dividends reinvested · last 1y
IART -12.2% (-12.2%/yr)LBRX +100.1% (+100.1%/yr)LBRX compounded faster over this window
50100150200250300Start $1002026$88$200
IART LBRX

IART vs LBRX: by the numbers

  • •IART is the larger company ($1.04B vs $998M market cap).
  • •Both run net losses; LBRX's is the smaller (0.00% vs -0.44% net margin).

Metrics side by side

Valuation

MetricIARTLBRX
Forward P/E5.47N/A
P/S ratio0.63N/A
P/B ratio0.993.00
EV / EBITDA3.54N/A

Profitability

MetricIARTLBRX
Gross margin53.74%0.00%
Operating margin4.18%0.00%
Net margin-0.44%0.00%
ROE-0.69%-25.78%
ROIC20.01%-28.14%

Growth (annualized)

MetricIARTLBRX
Revenue CAGR (5Y)1.77%N/A
Total return CAGR (5Y)-28.16%N/A

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.